Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: Results of a phase I single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability. - Nambiar, A; Kellogg, D; Justice, J (EBioMedicine, 2023)